Provided by Integrity Continuing Education, Inc.
Supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
Atopic dermatitis (AD) is a chronic relapsing‐remitting inflammatory skin condition that affects an estimated 9.8% of children in the United States and is associated with significant disability and poor quality of life. Over the past decade, substantial progress has occurred in the development of advanced therapies capable of improving response in poorly controlled AD. It has been noted that a key challenge to the implementation of new AD therapies can be a lack of prescriber confidence from being unfamiliar with their respective mechanisms of action. Overcoming this requires up-to-date knowledge of AD pathophysiology, along with education on newer therapies that have been approved or are in late-stage development. In addition to optimizing treatment selection, effective management strategies, such as shared decision-making and multidisciplinary care, play a key role in improving therapeutic response among patients with AD.
CME-certified Meet-Ups include a live expert faculty narration, case-based learning, and live peer-to-peer audience discussion. Attendance is limited to 25 participants.
8:00 PM – 8:30 PM Presentation & Case Study Discussion
8:30 PM – 8:45 PM Expert Access & Question/Answer Session
Anthony J. Mancini, MD, FAAP, FAAD
Head, Division of Dermatology
Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor of Pediatrics and Dermatology
Northwestern University Feinberg School of Medicine
This educational activity has been designed to meet the needs of dermatologists, senior dermatology residents, and other members of the healthcare team who manage treatment for patients with AD.
Upon completion of this educational activity, participants should be able to:
There are no fees for participating and receiving CME credit for this activity. To receive credit, participants must:
A statement of credit will be issued only upon receipt of a completed activity evaluation form. Your certificate will be sent to you within 4 weeks of receipt of the completed evaluation.
Physician Continuing Education
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Integrity Continuing Education, Inc. designates this live activity for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or email@example.com.
Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.
The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of these CME activities:
Anthony J. Mancini, MD, FAAP, FAAD
Advisory Board: Cassiopea, Castle Creek, Novartis
Consultant/Advisor: ParaPRO, Verrica
Speakers’ Bureau: Cassiopea, Sanofi Genzyme
The Integrity Continuing Education, Inc. planners and managers have nothing to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)
Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe® Flash® Player 10
Adobe® Flash® Player 10 plug-in should be downloaded
Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus
For optimal performance, the use of Internet Explorer below 8 is not recommended
For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
On the day of the program, you may access the event by going to:
Live Interactive Meet-Up: https://integrityce.com/ADMeetUp-3
There are no fees for participating and receiving CME credit for this activity. For your participation you will be able to receive a maximum of 0.75 AMA PRA Category 1 CME creditTM . To do so, you must participate in the virtual livestream activity and complete the posttest and evaluation following the event. A statement of credit will be issued within 4 weeks of submission of a completed activity evaluation form.